Weiping Xu
Impact in
- Environmental Chemistry top 10%
- Per- and polyfluoroalkyl substances research
-
- MicroRNA in disease regulation
Papers in
-
- T-cell and B-cell Immunology 2
- Atherosclerosis and Cardiovascular Diseases 2
- Galectins and Cancer Biology 1
- Co-authors
- Lisong Shen (5 shared papers)Linhong Deng (3 shared papers)Zhong‐Cheng Luo (2 shared papers)Ruxianguli Aimuzi (2 shared papers)Qing Du (2 shared papers)Guoqi Yu (2 shared papers)Sisi Wei (3 shared papers)Ying Tian (2 shared papers)
- Journals
- Oncotarget (2 papers)Journal of Nuclear Cardiology (2 papers)Environment International (1 paper)Cancer Biomarkers (1 paper)Annals of Translational Medicine (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Weiping Xu
21 papers receiving 379 citations
Peers
Comparison fields: 5 of 74
- Environmental Chemistry 69
- Cancer Research 48
- Obstetrics and Gynecology 23
- Immunology 61
- Health, Toxicology and Mutagenesis 39
Countries citing papers authored by Weiping Xu
This map shows the geographic impact of Weiping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiping Xu more than expected).
Fields of papers citing papers by Weiping Xu
This network shows the impact of papers produced by Weiping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiping Xu. The network helps show where Weiping Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiping Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 101 | |
| 2 | Expression profile analysis of circulating microRNAs and their effects on ion channels in Chinese atrial fibrillation patients. | 2015 | 41 |
| 3 | 2015 | 39 | |
| 4 | 2017 | 37 | |
| 5 | 2015 | 26 | |
| 6 | 2016 | 23 | |
| 7 | 2013 | 22 | |
| 8 | 2015 | 19 | |
| 9 | 2016 | 13 | |
| 10 | 2014 | 10 | |
| 11 | 2015 | 8 | |
| 12 | 2012 | 7 | |
| 13 | 2020 | 7 | |
| 14 | 2019 | 7 | |
| 15 | 2023 | 5 | |
| 16 | 2022 | 5 | |
| 17 | [MicroRNA-182 modulates high glucose-induced cardiomyocyte hypertrophy via targeting Rac1]. | 2015 | 4 |
| 18 | 2021 | 3 | |
| 19 | 2014 | 1 | |
| 20 | 2020 | 1 |
About Weiping Xu
Weiping Xu is a scholar working on Molecular Biology, Immunology, Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 22 papers that have together received 380 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (2 papers), Per- and polyfluoroalkyl substances research (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), Cardiac Imaging and Diagnostics (2 papers), Ultrasound and Hyperthermia Applications (1 paper), Nitric Oxide and Endothelin Effects (1 paper), Advanced X-ray and CT Imaging (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Environmental Chemistry (69 citations), Cancer Research (48 citations), Obstetrics and Gynecology (23 citations), Immunology (61 citations) and Health, Toxicology and Mutagenesis (39 citations). Weiping Xu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Lisong Shen, Linhong Deng, Zhong‐Cheng Luo, Ruxianguli Aimuzi, Qing Du, Guoqi Yu, Sisi Wei, Ying Tian, Xiangliang Yuan and Guanghui Zhang. Their work appears in journals such as Oncotarget, Journal of Nuclear Cardiology, Environment International, Cancer Biomarkers and Annals of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.